Marusan-Ai Co., Ltd. (XNGO:2551)
3,560.00
-160.00 (-4.30%)
At close: Apr 7, 2025
Marusan-Ai Revenue
Marusan-Ai had revenue of 8.70B JPY in the quarter ending December 20, 2024, with 4.36% growth. This brings the company's revenue in the last twelve months to 33.52B, up 6.66% year-over-year. In the fiscal year ending September 20, 2024, Marusan-Ai had annual revenue of 33.16B with 7.13% growth.
Revenue (ttm)
33.52B
Revenue Growth
+6.66%
P/S Ratio
0.24
Revenue / Employee
75.50M
Employees
444
Market Cap
8.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 20, 2024 | 33.16B | 2.21B | 7.13% |
Sep 20, 2023 | 30.95B | 251.00M | 0.82% |
Sep 20, 2022 | 30.70B | 608.00M | 2.02% |
Sep 20, 2021 | 30.09B | 625.00M | 2.12% |
Sep 20, 2020 | 29.47B | 2.09B | 7.65% |
Sep 20, 2019 | Pro | Pro | Pro |
Sep 20, 2018 | Pro | Pro | Pro |
Sep 20, 2017 | Pro | Pro | Pro |
Sep 20, 2016 | Pro | Pro | Pro |
Sep 20, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Toyota Motor | 46.75T |
Sony Group | 13.81T |
Mitsubishi UFJ Financial Group | 6,199.27B |
Hitachi | 9,521.78B |
Fast Retailing | 3,295.04B |
Keyence | 1,035.29B |
Chugai Pharmaceutical | 1,170.61B |
Sumitomo Mitsui Financial Group | 4,244.87B |